PlexusDx providers review your full medication profile before prescribing semaglutide injections, which are $189/mo month-to-month, or from $149/mo on the 6-month plan
10.1038/nbt0797-673 Nat
Semaglutide is approved for the treatment of obesity in a subcutaneous formulation at a dose of 2.4 mg OW
DL declares receipt of grants from Abbvie, Amgen, AstraZeneca, Bristol-Myers Squibb, Pfizer and Sanofi, and past participation in advisory boards and/or receipt of honoraria from Abbvie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Edwards Lifesciences, Novartis, Pfizer, Sanofi and Shire, outside the submitted work
Nutr Metab Insights
Additionally, the reduced appetite makes it easier to cut back on calorie intake, which helps with overall weight loss